Curis CRIS
NASDAQ CRIS
$1.61 -0.11 (-6.40%)
At close: Aug 20, 2026 · 4:00 PM EDT

Curis (CRIS) FCF Margin (2010 - 2025)

Curis' (CRIS) quarterly FCF Margin came in at 562.39% in Q4 2025, down 28556.0% YoY from N/an in Q4 2024, and down 222.47% on a QoQ basis from 174.4% in Q3 2025.

Curis (CRIS) FCF Margin (2010 - 2025) Analysis & Trends

Curis (CRIS) has 16 years of FCF Margin data on file, last reported at 562.39% in Q4 2025.

  • Quarterly FCF Margin fell 28556.0% year-over-year to 562.39% in Q4 2025, while the trailing twelve-month figure through Mar 2026 was 409.85% (down 11006.0% YoY) and the FY2025 annual result came in at 288.04%, up 7465.0% from the prior year.
  • FCF Margin fell to 562.39% in Q4 2025, from 174.4% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 174.4% in Q3 2025 to a low of 817.99% in Q1 2022.
  • A 5-year average of 407.04% and a median of 367.97% in 2023 frame the typical range for FCF Margin.
  • The widest YoY moves for FCF Margin: up 32962 bps in 2025, down 28556 bps in 2025.
  • Tracing CRIS's FCF Margin over 5 years: stood at 260.64% in 2021, then tumbled by 63 bps to 424.94% in 2022, then increased by 11 bps to 377.82% in 2023, then rose by 27 bps to 276.83% in 2024, then plunged by 103 bps to 562.39% in 2025.
  • The last three FCF Margin figures came in at 562.39% (Q4 2025), 174.4% (Q3 2025), and 291.34% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 30.39%
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 13.35%
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn -
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -388.28%
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 25.68%
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 22.62%
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -22.35%
8 Royalty Pharma 26.98 Bn 26.14 Bn - 70.82%
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 41.07%
10 Curis 3.44 Mn -2.18 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -562.39%
Sep 30, 2025 -174.40%
Jun 30, 2025 -291.34%
Mar 31, 2025 -304.71%
Dec 31, 2024 -276.83%
Sep 30, 2024 -202.52%
Jun 30, 2024 -437.35%
Mar 31, 2024 -634.32%
Dec 31, 2023 -377.82%
Sep 30, 2023 -288.78%
Jun 30, 2023 -358.12%
Mar 31, 2023 -531.08%
Dec 31, 2022 -424.94%
Sep 30, 2022 -466.34%
Jun 30, 2022 -521.73%
Mar 31, 2022 -817.99%
Dec 31, 2021 -260.64%
Sep 30, 2021 -316.22%
Jun 30, 2021 -291.29%
Mar 31, 2021 -602.06%